Filing Flows › Establishment Labs Holdings (ESTA) › Recalls, complaints & regulation
Establishment Labs Holdings (ESTA): clinical trials
Establishment Labs Holdings (ESTA) beyond its filings: 3 active clinical trials.
Establishment Labs Holdings' latest quarter
Establishment Labs Holdings, Q3 2026: revenue $72.0M (+34% year over year), operating margin -3.6%, net loss $10.7M, operating cash flow $7.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Establishment Labs Holdings have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.